Abstract
Apolipoprotein H (APO H) has recently been identified as a structural component of chylomicrons, very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL). Although the precise metabolic function of APO H in lipid metabolism is not certain, it has been suggested that APO H may be involved in triglyceride (TG) metabolism. In addition to the previously described quantitative polymorphism, we have recently detected a common qualitative polymorphism at the APO H structural locus. To test the role of APO H genetic variation in determining lipoprotein and lipid levels, we have estimated the allelic effects of APO H variation on TG, VLDL, LDL, HDL, HDL3, and total cholesterol on 356 Nigerian blacks (189 males, 167 females). While no significant effect of phenotype was observed on lipoprotein levels, the effect of interaction between phenotype and gender was significant. Therefore, data on males and females were analyzed separately using analysis of variance after adjusting for age and body mass index. Logarithmic transformation of pertinent variables was done to bring the distribution of the variables closer to normality. A statistically significant effect of phenotype was observed on triglyceride levels in females only (P less than 0.05). Further analysis of this phenotypic effect revealed that it is due to the impact of the APO H*3 allele, which raises triglycerides by 9.92 mg/dl as compared to the common allele, APO H*2. These findings are in accordance with the postulated role of APO H in triglyceride metabolism. On the basis of its sex-specific effect, we propose a hypothesis that may explain the combined influence of the quantitative and qualitative polymorphisms at the APO H locus on triglyceride levels in females.
MeSH Terms
Cholesterol/blood
Cholesterol, HDL/blood
Cholesterol, LDL/blood
Female
Genetic Variation
Glycoproteins/genetics,physiology
Humans
Immunoblotting
Isoelectric Focusing
Lipoproteins, HDL/blood
Lipoproteins, HDL3
Male
Nigeria
Phenotype
Polymorphism, Genetic
Sex Factors
beta 2-Glycoprotein I
Chemicals
Cholesterol, HDL
Cholesterol, LDL
Glycoproteins
Lipoproteins, HDL
Lipoproteins, HDL3
beta 2-Glycoprotein I
Cholesterol
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Sepehrnia B
Human Genetics Division, Graduate School of Public Health, University of Pittsburgh, PA 15261.
Kamboh M I
Adams-Campbell L L
Bunker C H
Nwankwo M
Majumder P P
Ferrell R E
References (23)
23 references, click to expand
-
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
Clin Chem. 1972 Jun;18(6):499-502
PMID: 4337382
-
Binding of beta 2-glycoprotein-I to intralipid: determination of the dissociation constant.
Biochem Biophys Res Commun. 1979 Oct 29;90(4):1305-12
PMID: 518599
-
Quantitative determination of serum triglycerides by the use of enzymes.
Clin Chem. 1973 May;19(5):476-82
PMID: 4703655
-
The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods.
Ann Hum Genet. 1986 May;50(Pt 2):181-94
PMID: 3435047
-
A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.
J Lipid Res. 1978 Jan;19(1):65-76
PMID: 202660
-
The relation of sex, smoking status, birth rank, and parental age to beta2-glycoprotein I levels and phenotypes in a sample of Australian Caucasian adults.
Hum Genet. 1978 Sep 19;43(3):281-8
PMID: 700702
-
[Genetic studies on the deficiency of beta 2-glycoprotein I of human serum].
Humangenetik. 1968;5(4):294-304
PMID: 5670608
-
A sensitive immunoblotting technique to identify thyroxin-binding globulin protein heterogeneity after isoelectric focusing.
Biochem Genet. 1986 Apr;24(3-4):273-80
PMID: 3089215
-
The general relationship between average effect and average excess.
Genet Res. 1987 Feb;49(1):69-70
PMID: 3569910
-
Assessment of cardiovascular risk factors in Nigerian students.
Arteriosclerosis. 1988 Nov-Dec;8(6):793-6
PMID: 3196223
-
On the population genetics of beta2-glycoprotein I.
Hum Hered. 1979;29(4):236-41
PMID: 478560
-
Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.
Am J Hum Genet. 1985 Mar;37(2):268-85
PMID: 3985008
-
Complete amino acid sequence of human plasma beta 2-glycoprotein I.
Proc Natl Acad Sci U S A. 1984 Jun;81(12):3640-4
PMID: 6587378
-
The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions.
FEBS Lett. 1979 Jun 1;102(1):183-6
PMID: 222615
-
Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I).
Biochem Biophys Res Commun. 1980 Aug 14;95(3):1168-72
PMID: 7417307
-
Studies on the possible function of beta 2-glycoprotein-I: influence in the triglyceride metabolism in the rat.
Metabolism. 1982 May;31(5):484-6
PMID: 7078428
-
Binding of beta 2-glycoprotein I to platelets: effect of adenylate cyclase activity.
Thromb Res. 1980 Jul 1-15;19(1-2):225-37
PMID: 7444854
-
DNA polymorphisms of the apolipoprotein genes--their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis.
Atherosclerosis. 1988 Aug;72(2-3):89-108
PMID: 3063270
-
Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (beta 2-glycoprotein I).
Am J Hum Genet. 1988 Mar;42(3):452-7
PMID: 3348213
-
beta 2-Glycoprotein I. Molecular properties of an unusual apolipoprotein, apolipoprotein H.
J Biol Chem. 1983 Apr 25;258(8):4765-70
PMID: 6403535
-
Investigations on the genetics and population genetics of the beta 2-glycoprotein I polymorphism.
Humangenetik. 1970;9(2):164-71
PMID: 5423929
-
Apolipoprotein genetic variation and human disease.
Physiol Rev. 1988 Jan;68(1):85-132
PMID: 2892216
-
Enzymatic determination of total serum cholesterol.
Clin Chem. 1974 Apr;20(4):470-5
PMID: 4818200